Healthcare provider profile · identity verified

Gale Evans Jackson, M.D.

Family Practice · CLARKSVILLE, TN · NPI 1437315470

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	242	71
Albuterol Sulfate Hfa	Albuterol Sulfate	223	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	188	38
Gabapentin	Gabapentin	168	29
Atorvastatin Calcium	Atorvastatin Calcium	164	51
Lisinopril	Lisinopril	156	51
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	132	18
Montelukast Sodium	Montelukast Sodium	131	39
Pantoprazole Sodium	Pantoprazole Sodium	129	45
Prednisone	Prednisone	115	65
Baclofen	Baclofen	111	29
Rosuvastatin Calcium	Rosuvastatin Calcium	109	32
Fluticasone Propionate	Fluticasone Propionate	108	47
Levothyroxine Sodium	Levothyroxine Sodium	108	34
Alprazolam	Alprazolam	93	14
Furosemide	Furosemide	93	22
Omeprazole	Omeprazole	87	33
Hydrochlorothiazide	Hydrochlorothiazide	72	26
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Metformin Hcl Er	Metformin Hcl	67	21
Zolpidem Tartrate	Zolpidem Tartrate	67	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	66	suppressed
Potassium Chloride	Potassium Chloride	65	17
Tamsulosin Hcl	Tamsulosin Hcl	63	14
Celecoxib	Celecoxib	61	15
Duloxetine Hcl	Duloxetine Hcl	60	15
Metformin Hcl	Metformin Hcl	60	19
Metoprolol Succinate	Metoprolol Succinate	59	20
Losartan Potassium	Losartan Potassium	58	21
Simvastatin	Simvastatin	58	17
Oxycodone Hcl	Oxycodone Hcl	56	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	11
Pravastatin Sodium	Pravastatin Sodium	54	17
Meloxicam	Meloxicam	53	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	42
Carvedilol	Carvedilol	48	16
Lorazepam	Lorazepam	48	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	46	37
Trazodone Hcl	Trazodone Hcl	46	14
Glipizide Er	Glipizide	45	13
Ibuprofen	Ibuprofen	44	suppressed
Alendronate Sodium	Alendronate Sodium	43	13
Eliquis	Apixaban	43	suppressed
Methocarbamol	Methocarbamol	43	suppressed
Allopurinol	Allopurinol	37	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	15
Dicyclomine Hcl	Dicyclomine Hcl	37	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	36	suppressed
Xarelto	Rivaroxaban	36	suppressed
Atenolol	Atenolol	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Linzess	Linaclotide	33	suppressed
Sucralfate	Sucralfate	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Benazepril Hcl	Benazepril Hcl	31	suppressed
Sertraline Hcl	Sertraline Hcl	31	13
Clonazepam	Clonazepam	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	12
Famotidine	Famotidine	28	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Telmisartan	Telmisartan	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Spironolactone	Spironolactone	26	11
Sumatriptan Succinate	Sumatriptan Succinate	26	suppressed
Farxiga	Dapagliflozin Propanediol	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Ondansetron Odt	Ondansetron	22	11
Ozempic	Semaglutide	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	13
Buspirone Hcl	Buspirone Hcl	21	suppressed
Fluconazole	Fluconazole	21	16
Hydroxyzine Hcl	Hydroxyzine Hcl	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	17
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Jardiance	Empagliflozin	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Azithromycin	Azithromycin	17	13
Lansoprazole	Lansoprazole	17	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Topiramate	Topiramate	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Mounjaro	Tirzepatide	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Lovastatin	Lovastatin	15	suppressed
Ramelteon	Ramelteon	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Glipizide	Glipizide	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Jentadueto	Linagliptin/Metformin Hcl	12	suppressed
Leflunomide	Leflunomide	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error